5Fernandez NC, Lozier A, Flament C, et al. Dendritic cells directly trigger NK cell functions: croos-talk relevant in innate anti - tumor immune responses in vivo[ J]. Nat Med, 1999,5:405 - 411.
6Chen SR, Akbar SMF,Tanimoto K, et al. Absence of CD83 positive mature and activated dendritic cells at cancer nodules from patients with hepatocellular carcinoma relevance to hepatocarcinogenesis[ J]. Cancer Letters,2000. 148:49 - 57.
7Mackensen A, Herbst B, Che JL, et al. Phase I study in melanima patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34( + )hematopoietic progenitor cells [ J]. Int J Cancer, 2000,86(3) :358 - 392.
8Krause SW,Neumann C,Soruri A, et al. The treatment of patients with disseminated matignant melanoma by vaccination with autologous cell hybrids of tumor cells and dendritic cells [ J ]. Journal of Immunotherapy,2002,25(5) :421 - 428.
9Morse MA, Coleman RE, Akabani G, et al. Migration of human dendritic cells after injection in patients with metastatic malignancies[ J]. Cancer Res, 1999,59(1) :56 - 58.
10Tfiozzi PL, Khurram R, Aldrich WA, et al. Intratumoral injection of dendritic cells derived in vitro in patients with metastatic cancer[ J] . Cancer,2000,89 (12) : 2646 - 2654.
二级参考文献94
1[1]Banchereau J,Steinman R. Dendritic cell and the control of immunity [J].Nature,1998;392(19):245-252.
2[2]Mellman I,Steinman R. Dendritic cells: specialized and regulated antigenprocessing machine[J].Cell,2001;106:255-258.
3[3]Paglia P, Chiodonio M, Rodolfo, et al.Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo[J].J Exp Med,1996;183:317-322.
4[4]Zitvogel L, Mayordomo JI,Tjandrawn AB, et al.Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells ,B7 costimulation,and T helper cell 1-associated cytokines[J]. J Exp Med,1996;183:87-97.
5[5]Liu YJ. Dendritic cell subsets and lingeages, and their functions in innate and adaptive immunity[J].Cell,2001;106:259-262.
6[6]Lanzavecchia A,Sallusto F. Regulation of T cell immunity by dendritic cells[J].Cell,2001,105:263-269.
7[7]Dallal R, Christakos P, Lee K,et al.Paucity of dendritic cells in pancreatic cancer[J]. Surgery, 2002;131(2): 135-8.
8[8]Brown R,Pope B,Murray A,et al. Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10[J]. Blood,2001;98(10): 2992-8.
9[9]Biragyn A,Kawk L. Designer cancer vaccines are still in fasion[J].Nat Med,2000;5(9):966-967.
10[10]Santin AD, Bellone S, Ravaggi A .Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer[J]. Br J Cancer. 2002 Jan 7; 86(1): 151-7.
